TPO-RA was given in doses of 1 μg/kg, 10 μg/kg, and 100 μg/kg (low-dose group, mid-dose group, and high-dose group, respectively) for the treatment of ITP in pregnancy. The gene discussed is TPO; the disease is autoimmune thrombocytopenic purpura.